breast cancer

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

Genetic test could help some breast cancer patients avoid radiation after lumpectomy

By Denise Mann Health Day Reporter (Health Day) FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test could help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor. People with invasive breast cancer who had low scores on an experimental gene panel were just as …

Genetic test could help some breast cancer patients avoid radiation after lumpectomy Read More »

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model

SALT LAKE CITY, 08 Dec. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated and more accurate predictor of breast cancer risk than a simple standard of care risk assessment. The data was shared …

Myriad Genetics Patient Outcome Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard Risk Model Read More »

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

A featured discussion sheds light on how the Combined Risk Score can lead to better breast cancer prevention and screening strategies. SALT LAKE CITY, Nov. 29, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc.., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new data presentations at the San Antonio Breast Cancer …

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment Read More »

Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive Grants

Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive Grants

Can a progesterone tracer predict treatment response? Breast cancer oncologist Linden, Athena Emeritus Professor of Breast Cancer Research at UW School of Medicine, and nuclear medicine physician Delphine Chen, received funding from the BCRF, as well as the breast cancer translational research consortium and drugmaker Eli Lilly, to lead a multicenter collaborative study with partner …

Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive Grants Read More »